MS research suggests the disease may be divided into two biological subtypes that differ in how early and aggressively nerve damage develops.
In certain cases, regulators will now be open to clearing therapies based on their ability to eliminate tumor cells, a change ...
Payami’s study, “Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms," was recently published in Nature Communications. Payami and her team reported ...
The MajesTEC-9 trial showed a 40% reduced risk of death and a 71% reduced risk of disease progression or death with ...
A collaboration including Rice University, Baylor College of Medicine and Texas Children’s Hospital’s Jan and Dan Duncan Neurological Research Institute (NRI) has produced a breakthrough in how to ...
7don MSN
New ALS treatment target identified: STAUFEN-1 protein reduction protects brain cells from death
University of Utah researchers at the Pulst-Scoles Laboratory have discovered that reducing levels of the STAUFEN-1 protein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback